Safety and Efficacy of Peptide Receptor Radionuclide Therapy in Multiple Endocrine Neoplasia Syndrome: A Single-center Experience
177 Lu-DOTATATE is a safe and effective treatment option for advanced NETs in MEN syndrome. However, large-sized multicentric prospective studies are required.
Authors
- Sanjay Kumar Bhadada (ORCID: https://orcid.org/0000-0002-0410-8778)
- Rama Walia (ORCID: https://orcid.org/0000-0002-6633-923X)
- Swayamjeet Satapathy (ORCID: https://orcid.org/0000-0001-5318-6644)
- Gurjeet Kaur (ORCID: https://orcid.org/0000-0002-6232-5703)
- Bhagwant Rai Mittal (ORCID: https://orcid.org/0000-0002-0016-5783)
- Ashwani Sood (ORCID: https://orcid.org/0000-0001-7228-0361)
- Piyush Aggarwal (ORCID: https://orcid.org/0000-0002-3067-3113)
- Rajesh Gupta (ORCID: https://orcid.org/0000-0002-6585-1725)
Institutions
- Endocrinology Research Center (RU)
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1097/rlu.0000000000005891
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35